Biosplice is a California-based biotechnology firm that develops and commercializes small-molecule therapeutics based on pre-mRNA splicing for cancer and Alzheimer's disease... Read more
Biosplice is a California-based biotechnology firm that develops and commercializes small-molecule therapeutics based on pre-mRNA splicing for cancer and Alzheimer's disease... Read more
2008
PrivateIndependent Company
News
Jun 13, 2024
Benzinga
Biosplice Therapeutics: Biosplice Announced Collaboration with Novo N...
Apr 22, 2024
Endpoints News
Biosplice Therapeutics: Biosplice searches for a path forward after osteoarthritis drug fails late-stage study
Apr 18, 2024
Benzinga
Biosplice Therapeutics: Biosplice Announces Upcoming Presentation of Successful OA-07 Phase 3 Long-Term Structure and Pain & Function Results for Lorecivivint for Treatment of Knee Osteoarthritis at OARSI Conference, and Completion and Preliminary Analysis of OA-21 Trial 12-Week Pain Results
Apr 11, 2024
StreetInsider
Press Release: Biosplice Therapeutics : Biosplice Announces Upcoming Presentation of Successful OA-07 Phase 3 Long-Term Structure and Pain & Function Results for Lorecivivint for Treatment of Knee Osteoarthritis at OARSI Conference, and
Mar 08, 2024
BioSpace
Biosplice Therapeutics: Biosplice Therapeutics Announces Department of Defense (DoD) Award to Fund Collaboration with The Roskamp Institute to Advance its Neurology Program
Jan 01, 2024
StreetInsider
Press Release: Biosplice Therapeutics : Biosplice Announces Collaboration with Novo Nordisk in Diabetes
Dec 04, 2023
Korea Biomedical Review
Biosplice Therapeutics: Samil's partner Biosplice Therapeutics proves efficacy of osteoarthritis drug in phase 3 trial
Nov 13, 2023
GlobalNewswire
Press Release: Biosplice Therapeutics : Biosplice Presents Successful Structure and Pain Results from Completed Phase 3 Long-Term Extension Clinical Trial for Lorecivivint for the Treatment of Knee Osteoarthritis
Dec 17, 2022
Pharmabiz
Biosplice Therapeutics: Biosplice announces Interim data from phase 3 longterm extension trial in knee osteoarthritis and initiates new phase 3 trial
Nov 12, 2022
Life Care News
Biosplice Therapeutics: Biosplice Announces Data from Recent Clinical Trials in
